4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000100
Director sold 797 shares at an average $26.13 ($20,827)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenleaf Peter Director | 2026-07-02 | Sale 10b5-1 | −712 | $26.00 | $18,509 | 23,969 | D: show line 1 in the form |
| Greenleaf Peter Director | 2026-07-02 | Sale 10b5-1 | −85 | $27.27 | $2,318 | 23,884 | D: show line 2 in the form |
| Open-market sales · 797 sh · avg $26.13 · $20,827 | |||||||
Loading xslF345X06/wk-form4_1783458198.xml…